Acute Philadelphia chromosome-positive leukemia in an adolescent boy after liver transplantation

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 7, 2003, Pages 565-568

  Silliman, Christopher C ^a,b,e   Tyson, R Weslie ^d   Wei, Qi ^c   Karrer, Frederick G ^a   Davies, Stella M ^d   Blake, Marilyn ^c   McGavran, Loris ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Children's Hospital Colorado   (United States)

^c CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e Bonfils Blood Center   (United States)

Author keywords

Chronic myelogenous leukemia; Immunosuppression; Liver transplantation

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ADOLESCENT; ARTICLE; BCR ABL GENE; BLAST CELL CRISIS; BONE MARROW BIOPSY; CANCER REGRESSION; CASE REPORT; CHROMOSOME REARRANGEMENT; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; EPSTEIN BARR VIRUS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA; LIVER TRANSPLANTATION; LYMPHATIC LEUKEMIA; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; T CELL LEUKEMIA; T CELL LEUKEMIA SYNDROME; T CELL LYMPHOMA; T CELL LYMPHOMA SYNDROME; VIRUS INFECTION;

ADOLESCENT; FUSION PROTEINS, BCR-ABL; HUMANS; IMMUNOSUPPRESSION; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS;

EID: 0038309968     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200307000-00014     Document Type: Article

References (18)

1. Smith JL, Wilkinson ah, Hunsicker LG, et al. Increased frequency of posttransplant lymphomas in patients treated with cyclosporin, azathioprine, and prednisone. Transplant Proc. 1989;21:3199-3200.
2. Cleary ML, Warnke R, Sklar J. Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients. Clonal analysis based on immunoglobulin-gene rearrangements. N Engl J Med. 1984;310:477-482.
3. Arican A, Ozbek N, Baltaci V, et al. Philadelphia chromosome (+) T-cell acute lymphoblastic leukemia after renal transplantation. Transplant Proc. 1999;31:3242-3243.
4. Ferry JA, Jacobson JO, Conti D, et al. Lymphoproliferative disorders and hematologic malignancies following organ transplantation. Mod Pathol. 1989;2:583-592.
5. Frist WH, Biggs VJ. Chronic myelogenous leukemia after lymphoid irradiation and heart transplantation. Ann Thorac Surg. 1994;57:214-216.
6. Crist W, Carroll A, Shuster J, et al. Philadelphia chromosome-positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Blood. 1990;76:489-494.
7. Gaynon PS, Trigg ME, Heerema NA, et al. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia. 2000;14:2223-2233.
8. Silliman CC, MsGavran L, Wei Q, et al. Alternative splicing in wild-type AF10 and CALM cDNAs and in AF10-CALM and CALM-AF10 fusion cDNAs produced by the t(10;11)(p13-14;q14-q21) suggests a potential role for truncated AF10 polypeptides. Leukemia. 1998;12:1404-1410.
9. Maloney K, McGavran L, Murphy J, et al. TEL-AML1 fusion identifies a subset of children with standard risk acute lymphoblastic leukemia who have an excellent prognosis when treated with therapy that includes a single delayed intensification. Leukemia. 1999;13:1708-1712.
10. Varella-Garcia M, Hogan CJ, Odom LF, et al. Minimal residual disease (MRD) in remission t(8;21) AML and in vivo differentiation detected by FISH and CD34+ cell sorting. Leukemia. 2001;15:1408-1414.
11. Bloomfield CD, Goldman AI, Alimena G, et al. Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood. 1986;67:415-420.
12. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973;243:290-293.
13. Ben Neriah Y, Daley GQ, Mes-Masson AM, et al. The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. Science. 1986;233:212-214.
14. Clark SS, McLaughlin J, Crist WM, et al. Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL. Science. 1987;235:85-88.
15. van Rhee F, Hochhaus A, Lin F, et al. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias. Blood. 1996;87:5213-5217.
16. Anastasi J, Feng J, Dickstein JI, et al. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia. Leukemia. 1996;10:795-802.
17. Cen H, Williams PA, McWilliams HP, et al. Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders. Blood. 1993;81:1393-1403.
18. Swinnen LJ, Mullen GM, Carr TJ, et al. Aggressive treatment for postcardiac transplant lymphoproliferation. Blood. 1995;86:3333-3340.